| Patents for A61K 48 - Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy (86,964) |
|---|
| 04/09/2013 | CA2224176C Gene transfer for treating a connective tissue of a mammalian host |
| 04/04/2013 | WO2013049493A1 Inducible adeno -associated virus vector mediated transgene ablation system |
| 04/04/2013 | WO2013049307A2 Enhanced immune memory development by aptamer targeted mtor inhibition of t cells |
| 04/04/2013 | WO2013049200A1 Methods of treating periodontal inflammation and periodontal bone loss |
| 04/04/2013 | WO2013047941A1 Method for decreasing radioresistance and growth, metastasis and infiltration of cancer cells through regulating expression or activity of tm4sf4 in non-small cell lung cancer |
| 04/04/2013 | WO2013047889A1 Pharmaceutical composition for treating autoimmune diseases |
| 04/04/2013 | WO2013045639A1 LENTIVIRAL VECTORS PSEUDOTYPED WITH MUTANT BaEV GLYCOPROTEINS |
| 04/04/2013 | WO2013045488A1 Apc-mediated tolerance induction for therapy of multiple sclerosis |
| 04/04/2013 | WO2013045455A1 Spray system for production of a matrix formed in situ |
| 04/04/2013 | WO2013044607A1 System for evaluating anti-aging effect of autologous adipose-derived stem cells |
| 04/04/2013 | WO2013044419A1 Combined facilitator, antigen and dna vaccine for preventing and treating autoimmune diseases |
| 04/04/2013 | WO2013015586A9 Vaccine composition for preventing and treating colibacillosis and salmonellosis in poultry, containing a salmonella strain expressing virulence factors of pathogenic escherichia coli of poultry |
| 04/04/2013 | WO2013012921A3 Nucleic acid aptamers |
| 04/04/2013 | WO2013006688A3 N-terminal deleted gp120 immunogens |
| 04/04/2013 | WO2012177903A3 Methods of treating cognitive impairment |
| 04/04/2013 | WO2012174555A3 Composition and method for stabilization and delivery of therapeutic molecules |
| 04/04/2013 | WO2012174365A3 Methods for producing pancreatic precursor cells and uses thereof |
| 04/04/2013 | WO2012171024A3 Enzyme directed assembly of particle theranostics |
| 04/04/2013 | WO2012170742A3 Treatment and prevention of cancer with hmgb1 antagonists |
| 04/04/2013 | WO2012154756A9 Delaying the progression of diabetes |
| 04/04/2013 | WO2012128799A3 Treating schizophrenia |
| 04/04/2013 | WO2012109314A3 Potent hiv inhibitors targeting ccr5 and gp41 |
| 04/04/2013 | WO2012074842A3 Compositions and methods for treating neoplasia |
| 04/04/2013 | US20130085259 Method and carrier complexes for delivering molecules to cells |
| 04/04/2013 | US20130085173 Supercoiled minicircle dna for gene therapy applications |
| 04/04/2013 | US20130085096 Regulation of lung tissue by hedgehog-like polypeptides, and formulations and uses related thereto |
| 04/04/2013 | US20130084300 Diagnosis and prevention of cancer cell invasion |
| 04/04/2013 | US20130084263 Pharmaceutical kit and method for treating cancer |
| 04/04/2013 | CA2850253A1 Spray system for production of a matrix formed in situ |
| 04/04/2013 | CA2849045A1 Lentiviral vectors pseudotyped with mutant baev glycoproteins |
| 04/03/2013 | EP2574662A2 Apparatus and method for electroporation of biological samples |
| 04/03/2013 | EP2574170A2 Immunostimulatory and vaccine compositions |
| 04/03/2013 | CN1555268B Therapeutic agents comprising pro-apoptotic proteins |
| 04/03/2013 | CN1526018B Recombinant poxvirus for chimeric proteins of the human immunodeficiency virus |
| 04/03/2013 | CN103025876A Complexation of nucleic acids with disulfide-crosslinked cationic components for transfection and immunostimulation |
| 04/03/2013 | CN103025873A Treatment of sodium channel, voltage-gated, alpha subunit (scna) related diseases by inhibition of natural antisense transcript to scna |
| 04/03/2013 | CN103014063A Encephalitis virus protein as well as coding gene and application thereof |
| 04/03/2013 | CN103014045A Recombinant HBV (Hepatitis B Virus) vector for expressing specific HBVshRNA (Hepatitis B Virus Short Hairpin Ribonucleic Acid) as well as construction method and application of vector |
| 04/03/2013 | CN103014044A Encephalitis virus protein as well as coding gene and application thereof |
| 04/03/2013 | CN103013997A MiRNA for restricting activity of hyaluronidase and application thereof |
| 04/03/2013 | CN103013016A Medical carrier and medical composition and preparation method thereof |
| 04/03/2013 | CN103012566A Non-phosphorylation ligand combined with Grb7 protein SH2 structural domain and pharmaceutical application thereof |
| 04/03/2013 | CN103007294A Multivalent immunostimulation nanoformula, preparation method and application thereof |
| 04/03/2013 | CN103007293A Targeting polypeptide-gene composite as well as preparation method and application of composite |
| 04/03/2013 | CN103007292A MiR-3OB (Micro-Ribonucleic Acid-30b) composite for targeting microglia as well as preparation method and application of composite |
| 04/03/2013 | CN103007291A Composition for treating eye diseases by double-target/multi-target small nucleic acid and applications of composition |
| 04/03/2013 | CN103007281A Preparation method of multi-mechanism treatment tumor photo-thermal controlled-release long-circulation medicament transit system and application thereof |
| 04/03/2013 | CN103007263A Vaccine composition |
| 04/03/2013 | CN103006538A Ultrasonic microbubbles for treating arthritis and use thereof |
| 04/03/2013 | CN102268458B BA46 recombinant adeno-associated virus vector and construction method and application thereof |
| 04/03/2013 | CN102268453B LMP-1 recombinant adeno-associated virus (rAAV) vector and construction method as well as application thereof |
| 04/03/2013 | CN102174479B Oncolytic virus for targeted treatment of human tumors and application thereof |
| 04/03/2013 | CN102107008B DNA damage repair inhibitors for treatment of cancer |
| 04/03/2013 | CN101974529B TGF-beta specific siRNA containing free triphosphoric acid group and application thereof |
| 04/03/2013 | CN101889087B A complex molecule interfering the expression of target genes and preparing methods thereof |
| 04/03/2013 | CN101370513B Immunogenicity polypeptide composed of optimized concealed peptide derived from tumor antigen |
| 04/02/2013 | US8410070 Compositions and methods for treating cancer, inhibiting proliferation, and inducing cell death |
| 04/02/2013 | US8409856 Compositions and their uses directed to gemin genes |
| 04/02/2013 | US8409813 Treatment of cancer using TLR3 agonists |
| 04/02/2013 | US8409625 Conditioned decellularized native tissues for tissue restoration |
| 04/02/2013 | US8409566 Therapeutic and diagnostic applications based on the role of the CXCR-4 gene in tumorigenesis |
| 04/02/2013 | CA2565424C Macromolecule-containing sustained release intraocular implants and related methods |
| 04/02/2013 | CA2472647C Mammal prolactin variants |
| 04/02/2013 | CA2471145C Dna encoding novel cyclic gmp dependent protein kinases from two protozoal sources for use as chemotherapeutic targets for antiprotozoal agents |
| 04/02/2013 | CA2457611C Novel molecular target for neurotoxicity |
| 04/02/2013 | CA2420543C Nucleic acid and corresponding protein named 158p1d7 useful in the treatment and detection of bladder and other cancers |
| 04/02/2013 | CA2201282C Viral material and nucleotide fragments associated with multiple sclerosis useful for diagnostic, preventive and therapeutic purposes |
| 03/28/2013 | WO2013044164A1 Methods to treat and/or prevent relapse in notch1-driven malignancies |
| 03/28/2013 | WO2013044044A2 Methods of treating fatty liver disease with helminth-derived glycan-containing compounds |
| 03/28/2013 | WO2013043196A1 Improved gene therapy methods |
| 03/28/2013 | WO2013042833A1 Pharmaceutical composition for the prevention or treatment of a prion disease containing an active ingredient in the form of the prnp gene using recombinant adenovirus vector |
| 03/28/2013 | WO2013041692A2 Method to predict the presence of inflammation or itaconic acid, irg1 and/or protein irg1 in a subject and pharmaceutical composition for treating or preventing inflammation |
| 03/28/2013 | WO2013041238A1 Use of kibra peptides, hdac inhibitor or proteasome inhibitor for improving anxiety disorders |
| 03/28/2013 | WO2013006558A3 Compositions and methods for treating skeletal myopathy |
| 03/28/2013 | WO2012165854A3 Long interfering dsrna simultaneously inducing an immune reaction and the inhibition of the expression of target genes |
| 03/28/2013 | WO2012159120A3 Gene therapy based strategy for treating hiv |
| 03/28/2013 | WO2011146879A3 Methods and compositions related to modulating autophagy |
| 03/28/2013 | US20130079387 Antisense oligonucleotide modulation of raf gene expression |
| 03/28/2013 | US20130078302 Protein C Zymogen and Methods of Use Thereof to Prevent Cancer Metastases |
| 03/28/2013 | US20130078266 Immunosuppression By Blocking T Cell Co-Stimulation Signal 2 (B7/CD28 Interaction) |
| 03/28/2013 | CA2849720A1 Improved gene therapy methods |
| 03/28/2013 | CA2849378A1 Nano delivery systems |
| 03/27/2013 | EP2573185A2 Lentiviral vectors and their use |
| 03/27/2013 | EP2573170A2 Adeno-associated virus (AAV) serotype 9 sequences, vectors containing same, and uses therefor |
| 03/27/2013 | EP2572780A1 Vesicles with encapsulated substance and production method therefor |
| 03/27/2013 | EP2572706A1 Lipid membrane structure with nuclear transferability |
| 03/27/2013 | EP2571530A2 Methods and compositions related to modulating autophagy |
| 03/27/2013 | CN1370083B Ninovasive genetic immnization, expression products therefrom, and uses thereof |
| 03/27/2013 | CN103003445A Method of determining the metastatic potential of a tumor |
| 03/27/2013 | CN103003430A Antisense molecules and methods for treating pathologies |
| 03/27/2013 | CN103003294A Gene fusion targeted therapy |
| 03/27/2013 | CN103002982A Vesicles with encapsulated substance and production method therefor |
| 03/27/2013 | CN103002906A Parathyroid hormone analogs and uses thereof |
| 03/27/2013 | CN103002900A Transcription factor decoys |
| 03/27/2013 | CN102998459A Biomarker for gastric cancer |
| 03/27/2013 | CN102994550A Method for expressing exogenous gene in animal cell or animal tissue |
| 03/27/2013 | CN102994549A Method of increasing the function of an aav vector |
| 03/27/2013 | CN102994508A Olmsted syndrome related gene identification, identification product, identification method, and use of identification |
| 03/27/2013 | CN102994503A SiRNA (small interfering ribose nucleic acid) for inhibiting homosapiens chromosome2open reading frame 3(C2 or f3) (GCF) gene expression, carrier of SiRNA for inhibiting GCF gene expression and application |
| 03/27/2013 | CN102994500A Methods for treating eye disorders |